Literature DB >> 7815820

Long-term survival of dopaminergic neurones in free-floating roller tube cultures of human fetal ventral mesencephalon.

C Spenger1, L Studer, L Evtouchenko, M Egli, J M Burgunder, R Markwalder, R W Seiler.   

Abstract

Transplantation of human fetal ventral mesencephalon (VM) to Parkinsonian patients has shown beneficial effects in several clinical trials. However, further improvements in the transplantation technique are needed. Delayed surgery, i.e., the in vitro maintenance of the tissue prior to transplantation would present several advantages. The roller tube technique as initially described by Gähwiler (1981) was modified in several aspects for the long-term maintenance of dopaminergic neurones of human fetal VM. Tissue cultures were maintained free-floating in the medium for up to 42 days. The human fetal material was obtained from legal induced suction abortions. The embryonic age ranged from 5 to 12 weeks post-conception. Identification of VM was possible in 43% of the cases. Neurones in cultures were demonstrated by means of immunohistochemistry for tyrosine hydroxylase (TH) and gamma-amino butyric acid (GABA), by electron microscopy and by hybridisation histochemistry using a TH-mRNA-sensitive probe. A high variability in the number of TH-positive cells in individual cultures derived from the same embryo was observed. In 20 microns frozen sections of such tissue cultures the mean +/- SEM of TH-positive cells was 6.5 +/- 1.2/0.1 mm2 (n = 79; range: 0-73). The technique described insures the growth of long-term cultures of human fetal VM.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7815820     DOI: 10.1016/0165-0270(94)90160-0

Source DB:  PubMed          Journal:  J Neurosci Methods        ISSN: 0165-0270            Impact factor:   2.390


  8 in total

1.  Organotypic cultures of free-floating slices of human embryo medulla oblongata.

Authors:  V M Vostrikov; N S Kolomeets; O P Aleksandrova; I V Viktorov; N A Uranova; G T Sukhikh
Journal:  Neurosci Behav Physiol       Date:  2005-01

Review 2.  Ethical issues in neurografting of human embryonic cells.

Authors:  G J Boer
Journal:  Theor Med Bioeth       Date:  1999-09

3.  A Subpopulation of Dopaminergic Neurons Coexpresses Serotonin in Ventral Mesencephalic Cultures But Not After Intrastriatal Transplantation in a Rat Model of Parkinson's Disease.

Authors:  Stefano Di Santo; Stefanie Seiler; Angélique D Ducray; Morten Meyer; Hans Rudolf Widmer
Journal:  Cell Transplant       Date:  2016-11-07       Impact factor: 4.064

4.  Fetal ventral mesencephalon of human and rat origin maintained in vitro and transplanted to 6-hydroxydopamine-lesioned rats gives rise to grafts rich in dopaminergic neurons.

Authors:  C Spenger; N S Haque; L Studer; L Evtouchenko; B Wagner; B Bühler; U Lendahl; S B Dunnett; R W Seiler
Journal:  Exp Brain Res       Date:  1996-11       Impact factor: 1.972

5.  Antagonization of the Nogo-Receptor 1 Enhances Dopaminergic Fiber Outgrowth of Transplants in a Rat Model of Parkinson's Disease.

Authors:  Stefanie Seiler; Stefano Di Santo; Lukas Andereggen; Hans R Widmer
Journal:  Front Cell Neurosci       Date:  2017-05-26       Impact factor: 5.505

6.  A Combination of NT-4/5 and GDNF Is Favorable for Cultured Human Nigral Neural Progenitor Cells.

Authors:  Stefano Di Santo; Morten Meyer; Angélique D Ducray; Lukas Andereggen; Hans R Widmer
Journal:  Cell Transplant       Date:  2018-04-27       Impact factor: 4.064

7.  Nogo-A Neutralization Improves Graft Function in a Rat Model of Parkinson's Disease.

Authors:  Stefanie Seiler; Stefano Di Santo; Hans Rudolf Widmer
Journal:  Front Cell Neurosci       Date:  2016-04-05       Impact factor: 5.505

8.  Simultaneous Transplantation of Fetal Ventral Mesencephalic Tissue and Encapsulated Genetically Modified Cells Releasing GDNF in a Hemi-Parkinsonian Rat Model of Parkinson's Disease.

Authors:  Alberto Perez-Bouza; Stefano Di Santo; Stefanie Seiler; Morten Meyer; Lukas Andereggen; Alexander Huber; Raphael Guzman; Hans R Widmer
Journal:  Cell Transplant       Date:  2017-09       Impact factor: 4.064

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.